Top compounds associated with response to RP11-526A4.1


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.01 0.7
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA linifanib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.025 0.7
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA VX-680 CTRPv2 pan-cancer AAC 0.039 0.7
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA procarbazine CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV